SI2546255T1 - Spojina benzazepina - Google Patents

Spojina benzazepina

Info

Publication number
SI2546255T1
SI2546255T1 SI201131007A SI201131007A SI2546255T1 SI 2546255 T1 SI2546255 T1 SI 2546255T1 SI 201131007 A SI201131007 A SI 201131007A SI 201131007 A SI201131007 A SI 201131007A SI 2546255 T1 SI2546255 T1 SI 2546255T1
Authority
SI
Slovenia
Prior art keywords
benzazepine compound
benzazepine
compound
Prior art date
Application number
SI201131007A
Other languages
English (en)
Inventor
Hiroyuki Koshio
Norio Asai
Taisuke Takahashi
Takafumi Shimizu
Yasuhito Nagai
Keiko Kawabata
Karl Bruce Thor
Original Assignee
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc. filed Critical Astellas Pharma Inc.
Publication of SI2546255T1 publication Critical patent/SI2546255T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
SI201131007A 2010-03-12 2011-03-11 Spojina benzazepina SI2546255T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31313310P 2010-03-12 2010-03-12
PCT/JP2011/055759 WO2011111817A1 (ja) 2010-03-12 2011-03-11 ベンゾアゼピン化合物
EP11753475.0A EP2546255B1 (en) 2010-03-12 2011-03-11 Benzazepine compound

Publications (1)

Publication Number Publication Date
SI2546255T1 true SI2546255T1 (sl) 2017-05-31

Family

ID=44563615

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131007A SI2546255T1 (sl) 2010-03-12 2011-03-11 Spojina benzazepina

Country Status (24)

Country Link
US (4) US20110269744A1 (sl)
EP (1) EP2546255B1 (sl)
JP (1) JP5747910B2 (sl)
KR (1) KR101769642B1 (sl)
CN (1) CN102869665B (sl)
AU (1) AU2011225108C1 (sl)
BR (1) BR112012022915B1 (sl)
CA (1) CA2792918C (sl)
CY (1) CY1118268T1 (sl)
DK (1) DK2546255T3 (sl)
EA (1) EA023039B1 (sl)
ES (1) ES2605466T3 (sl)
HR (1) HRP20161529T1 (sl)
HU (1) HUE031082T2 (sl)
IL (1) IL221737A (sl)
LT (1) LT2546255T (sl)
MX (1) MX338130B (sl)
PL (1) PL2546255T3 (sl)
PT (1) PT2546255T (sl)
RS (1) RS55362B1 (sl)
SI (1) SI2546255T1 (sl)
TW (1) TWI495640B (sl)
UA (1) UA110479C2 (sl)
WO (1) WO2011111817A1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
GB2520266A (en) * 2013-11-13 2015-05-20 Ibm Cursor-Based Character input interface
RS62017B1 (sr) * 2014-09-17 2021-07-30 Celgene Car Llc Mk2 inhibitori i njihova upotreba
US10452679B2 (en) * 2016-09-30 2019-10-22 Google Llc Systems and methods for context-sensitive data annotation and annotation visualization
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002074746A1 (ja) 2001-03-16 2004-07-08 山之内製薬株式会社 ベンゾアゼピン誘導体
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CN101274911B (zh) * 2003-06-17 2011-01-26 艾尼纳制药公司 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物
US20080009478A1 (en) 2003-10-22 2008-01-10 Arena Pharmaceuticals, Inc. Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
NZ586553A (en) * 2004-02-25 2011-11-25 Lilly Co Eli 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
GB0412314D0 (en) 2004-06-02 2004-07-07 Glaxo Group Ltd Compounds
TW201031661A (en) 2009-02-17 2010-09-01 Targacept Inc Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands

Also Published As

Publication number Publication date
JPWO2011111817A1 (ja) 2013-06-27
HUE031082T2 (en) 2017-06-28
AU2011225108B2 (en) 2014-11-06
TWI495640B (zh) 2015-08-11
CA2792918C (en) 2018-09-04
TW201144321A (en) 2011-12-16
US20110269744A1 (en) 2011-11-03
EP2546255A1 (en) 2013-01-16
RS55362B1 (sr) 2017-03-31
JP5747910B2 (ja) 2015-07-15
EP2546255B1 (en) 2016-08-31
US20130012496A1 (en) 2013-01-10
EA023039B1 (ru) 2016-04-29
BR112012022915B1 (pt) 2021-02-02
EA201290905A1 (ru) 2013-03-29
CN102869665B (zh) 2015-05-27
MX338130B (es) 2016-04-04
CA2792918A1 (en) 2011-09-15
AU2011225108C1 (en) 2015-05-07
KR101769642B1 (ko) 2017-08-18
PT2546255T (pt) 2016-12-07
MX2012010570A (es) 2012-11-23
AU2011225108A1 (en) 2012-09-27
WO2011111817A1 (ja) 2011-09-15
CY1118268T1 (el) 2017-06-28
LT2546255T (lt) 2016-12-12
US20150315208A1 (en) 2015-11-05
US9598434B2 (en) 2017-03-21
US9108977B2 (en) 2015-08-18
IL221737A (en) 2016-10-31
EP2546255A4 (en) 2014-09-03
US20130059837A1 (en) 2013-03-07
HRP20161529T1 (hr) 2016-12-30
ES2605466T3 (es) 2017-03-14
PL2546255T3 (pl) 2017-02-28
DK2546255T3 (en) 2016-12-19
CN102869665A (zh) 2013-01-09
KR20130038242A (ko) 2013-04-17
BR112012022915A2 (pt) 2018-05-22
UA110479C2 (en) 2016-01-12

Similar Documents

Publication Publication Date Title
IL223783A0 (en) Pro-neurogenic compounds
GB201008134D0 (en) Compounds
HK1187908A1 (zh) 咪唑並三嗪酮化合物
GB201007347D0 (en) Compounds
EP2605658A4 (en) SPIROXAZOLIDINONVERBINDUNGEN
EP2649050A4 (en) LINKS
GB201002563D0 (en) Compounds
IL219132A0 (en) Benzazepine compound
GB201008209D0 (en) Compounds
GB201001688D0 (en) Compounds
EP2546255A4 (en) BENZAZEPINE COMPOUND
GB201002911D0 (en) Compound
GB201017315D0 (en) Compound
GB201002216D0 (en) Compounds
GB201015537D0 (en) Compounds
GB201008210D0 (en) Compounds
GB201001796D0 (en) Compounds
GB201007209D0 (en) Compound
GB201021494D0 (en) Compounds
GB201021228D0 (en) Compound
GB201015798D0 (en) Compound
GB201008820D0 (en) Compound
GB201005980D0 (en) Compound
GB201022042D0 (en) Compounds
GB201019227D0 (en) Compounds